EVALUATION OF DISEASE-SPECIFIC SKIN SYMPTOM ITEMS ON SKINDEX-29 IN CUTANEOUS T-CELL LYMPHOMA PATIENTS TREATED WITH MOGAMULIZUMAB OR VORINOSTAT

Category Primary study
JournalValue in Health
Year 2018
This article has no abstract
Epistemonikos ID: 0ae5660177a8f95e56c5c072cd7dd94d1b9129d7
First added on: Feb 09, 2025